Skip to content

Fenfluramine for Lennox-Gastaut Syndrome: Long-Term Efficacy, Safety, and Outcomes Beyond Seizure Reduction

November 12, 2026 · 12 min

Show notes

How quickly does fenfluramine improve seizure control in patients with Lennox-Gastaut syndrome (LGS), and how do its efficacy and safety outcomes evolve over time? In this episode, Amélie Lothe, PhD, Global Medical Head, Rare Epilepsies and Neurodevelopmental Disorders, UCB, and coauthor of a recent study published in Epilepsia Open, discusses findings from a post hoc analysis of a phase 3 fenfluramine clinical trial and its open-label extension. 


Source: Nabbout R, Devinsky O, Lagae L, et al. Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study. Epilepsia Open. 2026 Oct;11:1871-1879. doi: 10.1002/epi4.70320. 

All episodes of Neurology: Disease Deep Dive

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.